LAVA Therapeutics NV

Filed a patent for "antibodies that bind gamma-delta t cell receptors for the treatment of cancer" on Thu, July 27, 2023

Filed a patent for "novel uses of multispecific antibodies that bind gamma-delta t cell receptors and a cancer antigen" on Mon, February 13, 2023

Filed a patent for "dual acting cd1d immunoglobulin for treatment of myelodysplastic syndromes" on Fri, June 9, 2023

Filed a patent for "immunoglobulins binding human vgamma9vdelta2 t cell receptors" on Thu, July 6, 2023

Filed a patent for "antibodies that bind psma and gamma-delta t cell receptors" on Thu, August 31, 2023

Filed a patent for "single domain antibodies targeting cd1d" on Thu, February 29, 2024

Filed a patent for "antibodies that bind gamma-delta t cell receptors" on Thu, September 28, 2023

Filed a patent for "antibodies that bind cd123 and gamma-delta t cell receptors" on Thu, May 2, 2024